On February 21, 2023, the “Saarländischer Rundfunk” SR featured Cysmic’s groundbreaking work in blood research. The segment featured Dr. Greta Simionato and Dr. Steffen Recktenwald, who demonstrated Cysmic’s Erysense measurement system. This innovative system, powered by artificial intelligence, accurately determines the deformability of red blood cells in small synthetic capillaries, providing a comprehensive assessment of blood sample quality. The program showcased current research findings on the shelf life of blood supplies and the effects of COVID-19 on blood flow in the human body, obtained through collaborative efforts between Cysmic, Saarland University, and other national and international institutes.
During the feature, CEO Dr. Stephan Quint introduced the heart of the Erysense technology—the microfluidic chip. This proprietary chip, developed by Cysmic, is employed for precise blood measurements. Its remarkable distinguishing factor lies in the numerous microchannels within the chip, each approximately 10 times thinner than a human hair. Cysmic ensures the production of these microchannels with utmost precision and at a large scale. In conclusion, Dr. Quint underscored the significance of Cysmic and Erysense in advancing blood research and providing a viable solution to the ongoing shortage of blood supplies.
Link (minutes 4:10-7:42):